Format

Send to

Choose Destination
JAMA Oncol. 2015 Jun;1(3):275-6. doi: 10.1001/jamaoncol.2015.35.

Using Somatic Mutations to Guide Treatment Decisions: Context Matters.

Author information

1
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
2
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada2Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada3Department of Computer Science, Univ.
3
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada2Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada4Department of Obstetrics and Gynecol.
PMID:
26181166
DOI:
10.1001/jamaoncol.2015.35
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center